The Rapid Flu/RSV assay is a quick and easy, next generation test that is designed to detect and differentiate Flu A, Flu B and RSV infection in order to rapidly exclude influenza as a likely diagnosis in suspected cases during outbreaks. This test is performed in Microbiology and is available routinely Mon to Sun and 24/7 ONLY during seasonal outbreaks.
During winter months Influenza and RSV can cause significant pressures on Hospital resources, bed utilisation and Infection control activities. Clinical diagnosis of these conditions is unreliable and standard diagnostics methods are lengthy. The “Rapid Flu / RSV” test is a molecular test for the detection of Influenza (no subtyping) and RSV. The assay can be used to rapidly exclude Influenza as a likely diagnosis in a suspected case. In admitted cases a “Respiratory panel standard” should also be sent, regardless of the result. The test should only be used when the Trust has identified there are significant pressures on isolation beds for admitted patients.
Working with our NHS service partners to set the standard for the future of pathology
Viapath is a founding member of The Association of Independent Pathology Providers (AIPP), which is a trade association representing innovative research-based diagnostic testing companies. www.pathologyassociation.com
Copyright 2014 Viapath Group LLP. Viapath, the Viapath logo and Nutris are registered trademarks of Viapath Group LLP.